PARISH FIELDS PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: D82031 | DISS, IP22 4WG
Showing results 351-400 of 592
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Verapamil hydrochloride | 47 | 3,584 | £177 | -48.2% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 47 | 1,470 | £607 | -29.9% ▼ |
| Rivastigmine | 46 | 2,522 | £477 | -33.1% ▼ |
| Ketoconazole | 46 | 6,240 | £1.1K | -53.2% ▼ |
| Chlorphenamine maleate | 45 | 4,624 | £156 | -59.2% ▼ |
| Ferrous gluconate | 45 | 2,100 | £61 | -5.9% ▼ |
| Other toiletry preparations | 45 | 21.2K | £232 | +5.4% ▲ |
| 45 | 4,805 | £324 | -47.1% ▼ | |
| Saxagliptin | 44 | 1,204 | £1.3K | +31.6% ▲ |
| Metronidazole | 44 | 2,030 | £681 | +17.1% ▲ |
| Colchicine | 42 | 1,874 | £35 | -46.1% ▼ |
| 42 | 229 | £588 | +73.7% ▲ | |
| 42 | 3,050 | £287 | -11.0% ▼ | |
| Primidone | 41 | 2,620 | £3.9K | +15.2% ▲ |
| 41 | 1,715 | £405 | -49.0% ▼ | |
| Ciprofibrate | 40 | 1,120 | £2.8K | +199.5% ▲ |
| Powder extensively hydrolysed formula (0913101) | 40 | 90.4K | £2.3K | -44.5% ▼ |
| 40 | 440 | £243 | -7.2% ▼ | |
| Hydroxyzine hydrochloride | 39 | 1,428 | £43 | -26.8% ▼ |
| Moxonidine | 38 | 1,064 | £147 | -31.7% ▼ |
| Water for injection | 38 | 274 | £165 | +12.3% ▲ |
| 38 | 2,600 | £5.0K | -22.0% ▼ | |
| 38 | 2,160 | £9.4K | -16.0% ▼ | |
| 37 | 5,580 | £9.3K | +74.8% ▲ | |
| Zolpidem tartrate | 36 | 941 | £39 | -60.0% ▼ |
| Lofepramine hydrochloride | 35 | 1,596 | £665 | +17.0% ▲ |
| Medroxyprogesterone acetate | 35 | 1,228 | £236 | -8.5% ▼ |
| Leflunomide | 35 | 1,050 | £64 | -7.5% ▼ |
| 35 | 1,070 | £252 | +56.7% ▲ | |
| Clonidine hydrochloride | 34 | 2,588 | £199 | +86.1% ▲ |
| Rasagiline mesilate | 34 | 952 | £585 | -8.5% ▼ |
| Tacrolimus | 34 | 3,500 | £5.6K | +27.1% ▲ |
| Urea | 34 | 19.4K | £1.2K | -49.1% ▼ |
| Dexamethasone | 33 | 1,412 | £342 | +5.9% ▲ |
| Tacrolimus | 33 | 1,080 | £876 | -38.8% ▼ |
| Other individually formulated bought in preparations | 33 | 2,446 | £342 | +1.0% vs avg |
| 33 | 119 | £5.1K | -7.6% ▼ | |
| Colestyramine | 32 | 1,758 | £453 | +11.1% ▲ |
| Duloxetine hydrochloride | 32 | 1,288 | £198 | -37.6% ▼ |
| 32 | 3,450 | £488 | -17.8% ▼ | |
| Sodium picosulfate | 31 | 7,700 | £689 | -14.6% ▼ |
| Prednisolone | 31 | 665 | £72 | -56.9% ▼ |
| Colesevelam hydrochloride | 31 | 5,580 | £1.9K | -18.3% ▼ |
| Erythromycin | 31 | 1,764 | £506 | -10.5% ▼ |
| Quinine bisulfate | 31 | 868 | £160 | -20.2% ▼ |
| Mefenamic acid | 31 | 3,336 | £774 | -31.4% ▼ |
| Tafluprost | 30 | 1,140 | £452 | +61.8% ▲ |
| Crotamiton | 30 | 2,640 | £157 | +80.4% ▲ |
| Flupentixol hydrochloride | 29 | 1,350 | £85 | -11.5% ▼ |
| Exenatide | 29 | 116 | £2.1K | +65.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.